loadpatents
Patent applications and USPTO patent grants for Walker; Joel R..The latest application filed is for "target engagement assay for ras proteins".
Patent | Date |
---|---|
Heteroaryl inhibitors of PDE4 Grant 11,401,286 - Gurney , et al. August 2, 2 | 2022-08-02 |
Inhibitors of oplophorus luciferase-derived bioluminescent complexes Grant 11,390,599 - Walker , et al. July 19, 2 | 2022-07-19 |
Target Engagement Assay For Ras Proteins App 20220064696 - Robers; Matthew B. ;   et al. | 2022-03-03 |
Cell impermeable coelenterazine analogues Grant 11,192,894 - Hall , et al. December 7, 2 | 2021-12-07 |
Heteroaryl Inhibitors Of Pde4 App 20200354384 - GURNEY; Mark E. ;   et al. | 2020-11-12 |
Functionalized NANOLUC inhibitors Grant 10,815,247 - Flemming , et al. October 27, 2 | 2020-10-27 |
Cell Impermeable Coelenterazine Analogues App 20200239475 - Hall; Mary ;   et al. | 2020-07-30 |
Coelenterazine analogues Grant 10,669,280 - Hall , et al. | 2020-06-02 |
Heteroaryl inhibitors of PDE4 Grant 10,626,129 - Gurney , et al. | 2020-04-21 |
Cell impermeable coelenterazine analogues Grant 10,577,370 - Hall , et al. | 2020-03-03 |
Thienopyrrole Compounds And Uses Thereof App 20200063110 - Duellman; Sarah ;   et al. | 2020-02-27 |
Coelenterazine Analogues App 20200062766 - Walker; Joel R. ;   et al. | 2020-02-27 |
Coelenterazine Analogues App 20190389869 - Hall; Mary ;   et al. | 2019-12-26 |
Thienopyrrole compounds and uses thereof Grant 10,513,694 - Duellman , et al. Dec | 2019-12-24 |
Inhibitors Of Oplophorus Luciferase-derived Bioluminescent Complexes App 20190382365 - Walker; Joel R. ;   et al. | 2019-12-19 |
Coelenterazine analogues Grant 10,428,075 - Hall , et al. October 1, 2 | 2019-10-01 |
Heteroaryl Inhibitors Of Pde4 App 20190270759 - GURNEY; Mark E. ;   et al. | 2019-09-05 |
Heteroaryl inhibitors of PDE4 Grant 10,364,258 - Gurney , et al. | 2019-07-30 |
Dual protected pro-coelenterazine substrates Grant 10,316,070 - Zhou , et al. | 2019-06-11 |
Substituted imidazo[1,2-A]pyrazines tethered to energy acceptors Grant 10,280,447 - Hall , et al. | 2019-05-07 |
Heteroaryl Inhibitors Of Pde4 App 20190055269 - GURNEY; Mark E. ;   et al. | 2019-02-21 |
Coelenterazine Analogues App 20180334463 - Hall; Mary ;   et al. | 2018-11-22 |
Heteroaryl inhibitors of PDE4 Grant 10,093,686 - Gurney , et al. October 9, 2 | 2018-10-09 |
Functionalized Nanoluc Inhibitors App 20180222916 - Flemming; Roderick G. ;   et al. | 2018-08-09 |
Coelenterazine analogues Grant 10,000,500 - Hall , et al. June 19, 2 | 2018-06-19 |
Cell Impermeable Coelenterazine Analogues App 20180155350 - Hall; Mary ;   et al. | 2018-06-07 |
Coelenterazine Analogues Tethered To Energy Acceptors App 20180119200 - Hall; Mary ;   et al. | 2018-05-03 |
Dual Protected Pro-coelenterazine Substrates App 20180072781 - Meisenheimer; Poncho ;   et al. | 2018-03-15 |
Coelenterazine Analogues App 20180030059 - Hall; Mary ;   et al. | 2018-02-01 |
Heteroaryl Inhibitors Of Pde4 App 20170342094 - GURNEY; Mark E. ;   et al. | 2017-11-30 |
Heteroaryl inhibitors of PDE4 Grant 9,777,024 - Gurney , et al. October 3, 2 | 2017-10-03 |
Thienopyrrole Compounds And Uses Thereof App 20160376568 - Duellman; Sarah ;   et al. | 2016-12-29 |
Tricyclic compounds and PBK inhibitors containing the same Grant 9,453,025 - Nakamura , et al. September 27, 2 | 2016-09-27 |
C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growth Grant 9,359,322 - Clagett-Dame , et al. June 7, 2 | 2016-06-07 |
1,5-naphthyridine derivatives and MELK inhibitors containing the same Grant 9,345,709 - Matsuo , et al. May 24, 2 | 2016-05-24 |
Heteroaryl Inhibitors Of Pde4 App 20160137672 - Gurney; Mark E. ;   et al. | 2016-05-19 |
Heteroaryl inhibitors of PDE4 Grant 9,221,843 - Gurney , et al. December 29, 2 | 2015-12-29 |
1,5-naphthyridine Derivatives And Melk Inhibitors Containing The Same App 20150328225 - MATSUO; Yo ;   et al. | 2015-11-19 |
Quinoline derivatives and MELK inhibitors containing the same Grant 9,120,749 - Matsuo , et al. September 1, 2 | 2015-09-01 |
Tricyclic Compounds and PBK Inhibitors Containing the Same App 20150183799 - NAKAMURA; Yusuke ;   et al. | 2015-07-02 |
1,5-naphthyridine derivatives and MELK inhibitors containing the same Grant 9,067,937 - Matsuo , et al. June 30, 2 | 2015-06-30 |
Heteroaryl Inhibitors Of Pde4 App 20150119362 - Gurney; Mark E. ;   et al. | 2015-04-30 |
Tricyclic compounds and PBK inhibitors containing the same Grant 8,962,648 - Nakamura , et al. February 24, 2 | 2015-02-24 |
1,5-naphthyridine Derivatives And Melk Inhibitors Containing The Same App 20150005302 - Matsuo; Yo ;   et al. | 2015-01-01 |
Quinoline Derivatives And Melk Inhibitors Containing The Same App 20130217671 - Matsuo; Yo ;   et al. | 2013-08-22 |
Nicotinic Acetylcholine Receptor Ligands And The Uses Thereof App 20130184313 - Chandrasekhar; Jayaraman ;   et al. | 2013-07-18 |
Tricyclic Compounds And Pbk Inhibitors Containing The Same App 20130178459 - Nakamura; Yusuke ;   et al. | 2013-07-11 |
Nicotinic acetylcholine receptor ligands and the uses thereof Grant 8,445,684 - Chandrasekhar , et al. May 21, 2 | 2013-05-21 |
Silent desensitizers of neuronal NACHR and methods of use thereof App 20110281836 - Walker; Joel R. ;   et al. | 2011-11-17 |
C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth Grant 8,026,220 - Clagett-Dame , et al. September 27, 2 | 2011-09-27 |
C-linked Glucuronide Of N-(4-hydroxybenzyl) Retinone, Analogs Thereof, And Methods Of Using The Same To Inhibit Neoplastic Cell Growth App 20110212906 - Clagett-Dame; Margaret ;   et al. | 2011-09-01 |
Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same App 20110190351 - Ohtani; Mitsuaki ;   et al. | 2011-08-04 |
Nicotinic Acetylcholine Receptor Ligands And The Uses Thereof App 20100152450 - Chandrasekhar; Jayaraman ;   et al. | 2010-06-17 |
C-linked Glucuronide Of N-(4-hydroxybenzyl) Retinone, Analogs Thereof, And Method Of Using The Same To Inhibit Neoplastic Cell Growth App 20090215706 - Clagett-Dame; Margaret ;   et al. | 2009-08-27 |
C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth Grant 7,528,114 - Clagett-Dame , et al. May 5, 2 | 2009-05-05 |
C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth App 20060287255 - Clagett-Dame; Margaret ;   et al. | 2006-12-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.